Cargando…

Neuraminidase-Inhibiting Antibody Response to H5N1 Virus Vaccination in Chronically Ill and Immunocompromised Patients

Neuraminidase-inhibiting (NAi) antibodies have been reported to be an independent correlate of protection from influenza disease, but the NAi antibody response to influenza vaccination has never been assessed in chronically ill or immunocompromised participants. Using an enzyme-linked lectin assay,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fritz, Richard, Hetzelt, Nicole, Ilk, Reinhard, Hohenadl, Christine, van der Velden, Maikel V. W., Aichinger, Gerald, Portsmouth, Daniel, Kistner, Otfried, Howard, M. Keith, Barrett, P. Noel, Kreil, Thomas R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2014
Materias:	Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4281780/ https://www.ncbi.nlm.nih.gov/pubmed/25734142 http://dx.doi.org/10.1093/ofid/ofu072

Ejemplares similares

H5N1 Whole-Virus Vaccine Induces Neutralizing Antibodies in Humans Which Are Protective in a Mouse Passive Transfer Model
por: Howard, M. Keith, et al.
Publicado: (2011)

Hyperimmune intravenous immunoglobulin containing high titers of pandemic H1N1 hemagglutinin and neuraminidase antibodies provides dose-dependent protection against lethal virus challenge in SCID mice
por: Hohenadl, Christine, et al.
Publicado: (2014)

A Cell Culture–Derived Influenza Vaccine Provides Consistent Protection Against Infection and Reduces the Duration and Severity of Disease in Infected Individuals
por: Ehrlich, Hartmut J., et al.
Publicado: (2012)

Immunogenicity and Protective Efficacy of a Vero Cell Culture-Derived Whole-Virus H7N9 Vaccine in Mice and Guinea Pigs
por: Wodal, Walter, et al.
Publicado: (2015)

Molecular Basis of the Divergent Immunogenicity of Two Pediatric Tick-Borne Encephalitis Virus Vaccines
por: Beck, Yvonne, et al.
Publicado: (2016)

Rapidly Increasing Severe Acute Respiratory Syndrome Coronavirus 2 Neutralization by Intravenous Immunoglobulins Produced From Plasma Collected During the 2020 Pandemic( )
por: Farcet, Maria R, et al.
Publicado: (2021)

A Pandemic Influenza H1N1 Live Vaccine Based on Modified Vaccinia Ankara Is Highly Immunogenic and Protects Mice in Active and Passive Immunizations
por: Hessel, Annett, et al.
Publicado: (2010)

Biomarkers for Diagnosing Febrile Illness in Immunocompromised Children: A Systematic Review of the Literature
por: van der Velden, Fabian J. S., et al.
Publicado: (2022)

Characterization of neuraminidase inhibitor-resistant influenza virus isolates from immunocompromised patients in the Republic of Korea
por: Kim, Heui Man, et al.
Publicado: (2020)

Antibody Neutralization of an Influenza Virus that Uses Neuraminidase for Receptor Binding
por: Gentles, Lauren E., et al.
Publicado: (2020)

Susceptibility of influenza viruses circulating in Western Saudi Arabia to neuraminidase inhibitors
por: Tolah, Ahmed M., et al.
Publicado: (2016)

Is this critically ill patient immunocompromised?
por: Pène, Frédéric, et al.
Publicado: (2015)

An inactivated West Nile Virus vaccine derived from a chemically synthesized cDNA system
por: Orlinger, Klaus K., et al.
Publicado: (2010)

Comparative thermostability analysis of zoonotic and human influenza virus A and B neuraminidase
por: Evseenko, Vasily A., et al.
Publicado: (2019)

Erratum to: Is this critically ill patient immunocompromised?
por: Pène, Frédéric, et al.
Publicado: (2016)

Superior In Vitro Stimulation of Human CD8(+) T-Cells by Whole Virus versus Split Virus Influenza Vaccines
por: Halbroth, Benedict R., et al.
Publicado: (2014)

Time to SARS-CoV-2 PCR Clearance in Immunocompromising Conditions: Is Test-Based Removal From Isolation Necessary in Severely Immunocompromised Individuals?
por: Epstein, Rachel L, et al.
Publicado: (2021)

Voriconazole-Resistant Penicillium oxalicum: An Emerging Pathogen in Immunocompromised Hosts
por: Chowdhary, Anuradha, et al.
Publicado: (2014)

Adverse events following yellow fever vaccination in immunocompromised persons
por: Lara, Amanda Nazareth, et al.
Publicado: (2021)

Surveillance of antiviral resistance markers in Argentina: detection of E119V neuraminidase mutation in a post-treatment immunocompromised patient
por: Pontoriero, Andrea, et al.
Publicado: (2016)

Detection and Characterization of Influenza B Virus With Reduced Neuraminidase Susceptibility in a Stem Cell Transplant Recipient
por: Kodiyanplakkal, Rosy Priya L, et al.
Publicado: (2019)

Gastrointestinal bleeding in critically ill immunocompromised patients
por: Catano, Jennifer, et al.
Publicado: (2021)

Emerging Influenza Strains in the Last Two Decades: A Threat of a New Pandemic?
por: Trombetta, Claudia, et al.
Publicado: (2015)

A rare case of endogenous Aspergillus conicus endophthalmitis in an immunocompromised patient
por: Smith, Wendy M, et al.
Publicado: (2013)

Longitudinal analysis of SARS‐CoV‐2 antibodies in 8000 U.S. first‐time convalescent plasma donations
por: Karbiener, Michael, et al.
Publicado: (2021)

Influenza neuraminidase
por: Air, Gillian M.
Publicado: (2011)

Inhibition of neuraminidase by Ganoderma triterpenoids and implications for neuraminidase inhibitor design
por: Zhu, Qinchang, et al.
Publicado: (2015)

Influenza Viruses and Vaccines: The Role of Vaccine Effectiveness Studies for Evaluation of the Benefits of Influenza Vaccines
por: Trombetta, Claudia Maria, et al.
Publicado: (2022)

Real-world Experience of Sotrovimab in High-risk, Immunocompromised COVID-19 Patients
por: Birk, Navina K, et al.
Publicado: (2022)

A double-inactivated whole virus candidate SARS coronavirus vaccine stimulates neutralising and protective antibody responses
por: Spruth, Martin, et al.
Publicado: (2006)

Diagnostic accuracy of procalcitonin in critically ill immunocompromised patients
por: Bele, Nicolas, et al.
Publicado: (2011)

A Whole Virus Pandemic Influenza H1N1 Vaccine Is Highly Immunogenic and Protective in Active Immunization and Passive Protection Mouse Models
por: Kistner, Otfried, et al.
Publicado: (2010)

Diagnosis of Neuroinvasive Astrovirus Infection in an Immunocompromised Adult With Encephalitis by Unbiased Next-Generation Sequencing
por: Naccache, Samia N., et al.
Publicado: (2015)

Clinical Correlation of Adenoviral Load in the Respiratory Tract Measured by Digital PCR in Immunocompromised Children
por: Hijano, Diego R, et al.
Publicado: (2023)

A neuraminidase potency assay for quantitative assessment of neuraminidase in influenza vaccines
por: Byrne-Nash, Rose T., et al.
Publicado: (2019)

Consecutive influenza surveillance of neuraminidase mutations and neuraminidase inhibitor resistance in Japan
por: Chong, Yong, et al.
Publicado: (2019)

Neuraminidase B controls neuraminidase A-dependent mucus production and evasion
por: Hammond, Alexandria J., et al.
Publicado: (2021)

How to assess the effectiveness of nasal influenza vaccines? Role and measurement of sIgA in mucosal secretions
por: Gianchecchi, Elena, et al.
Publicado: (2019)

Monitoring and managing SARS-CoV-2 evolution in immunocompromised populations
por: Li, Pengfei, et al.
Publicado: (2022)

SARS-CoV-2 viral load dynamics in immunocompromised critically ill patients on remdesivir treatment
por: Lahmer, Tobias, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p1jksitgg5bnaolq4kqoiof2s7